Anastasiou, M.; Oikonomou, E.; Theofilis, P.; Gazouli, M.; Papamikroulis, G.-A.; Goliopoulou, A.; Tsigkou, V.; Skandami, V.; Margoni, A.; Cholidou, K.;
et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908.
https://doi.org/10.3390/ph18121908
AMA Style
Anastasiou M, Oikonomou E, Theofilis P, Gazouli M, Papamikroulis G-A, Goliopoulou A, Tsigkou V, Skandami V, Margoni A, Cholidou K,
et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals. 2025; 18(12):1908.
https://doi.org/10.3390/ph18121908
Chicago/Turabian Style
Anastasiou, Maria, Evangelos Oikonomou, Panagiotis Theofilis, Maria Gazouli, George-Angelos Papamikroulis, Athina Goliopoulou, Vasiliki Tsigkou, Vasiliki Skandami, Angeliki Margoni, Kyriaki Cholidou,
and et al. 2025. "MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients" Pharmaceuticals 18, no. 12: 1908.
https://doi.org/10.3390/ph18121908
APA Style
Anastasiou, M., Oikonomou, E., Theofilis, P., Gazouli, M., Papamikroulis, G.-A., Goliopoulou, A., Tsigkou, V., Skandami, V., Margoni, A., Cholidou, K., Psyrri, A., Tsioufis, K., Zagouri, F., Siasos, G., & Tousoulis, D.
(2025). MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals, 18(12), 1908.
https://doi.org/10.3390/ph18121908
